Advances of epigenetic editing
- PMID: 32619853
- DOI: 10.1016/j.cbpa.2020.04.020
Advances of epigenetic editing
Abstract
Epigenetic editing refers to the locus-specific targeting of epigenetic enzymes to rewrite the local epigenetic landscape of an endogenous genomic site, often with the aim of transcriptional reprogramming. Implementing clustered regularly interspaced short palindromic repeat-dCas9 greatly accelerated the advancement of epigenetic editing, yielding preclinical therapeutic successes using a variety of epigenetic enzymes. Here, we review the current applications of these epigenetic editing tools in mammals and shed light on biochemical improvements that facilitate versatile applications.
Keywords: CRISPR/dCas; Epigenome editing; Expression reprogramming; Targeted DNA methylation; Targeted histone modifications.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: M.G.R. reports serving as a consultant to Sangamo Therapeutics, Richmond, CA.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
